NCT03536299

Brief Summary

The purpose of this study is to determine the utility of a performance measure for the dual-task of gait and considering people with multiple sclerosis have both cognitive and motor problems, the secondary aim of this study is to determine the effectiveness of a gait-specific dual-tasking intervention for ambulatory individuals with multiple sclerosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P75+ for not_applicable multiple-sclerosis

Timeline
Completed

Started May 2018

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 24, 2018

Completed
7 days until next milestone

Study Start

First participant enrolled

May 31, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2020

Completed
Last Updated

September 18, 2019

Status Verified

September 1, 2019

Enrollment Period

2 years

First QC Date

May 2, 2018

Last Update Submit

September 17, 2019

Conditions

Keywords

Physical therapyGait trainingCognitive-motor interferenceRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change in Walking and Remembering Test

    Measures dual-task cost of gait and a titrated forward digit span cognitive task, measured as a percentage.

    Week 1, Week 2, Week 5, Week 8, Week 12

Secondary Outcomes (6)

  • Change in 2-Minute Walk Test

    Week 1, Week 2, Week 5, Week 8, Week 12

  • Change in 12-Item Multiple Sclerosis Walking Scale

    Week 1, Week 2, Week 5, Week 8, Week 12

  • Change in Fatigue Scale for Motor and Cognitive Functions

    Week 1, Week 2, Week 5, Week 8, Week 12

  • Change in Gait Speed

    Week 1, Week 2, Week 5, Week 8, Week 12

  • Change in Gait Cadence

    Week 1, Week 2, Week 5, Week 8, Week 12

  • +1 more secondary outcomes

Other Outcomes (2)

  • Changes in Visual Analog Scale for Fatigue

    Week 1, Week 2, Week 5, Week 8, Week 12

  • Changes in Borg Rating of Perceived Exertion

    Week 1, Week 2, Week 5, Week 8, Week 12

Study Arms (2)

Single-Task Gait

ACTIVE COMPARATOR

The Single-Task Gait group will be provided with gait training without the Dual-Task cognitive tasks.

Other: Single-task gait

Dual-Task Gait

EXPERIMENTAL

The Dual-Task Gait group will be provided with gait training AND secondary cognitive tasks during gait training.

Other: Dual-task gait

Interventions

During the training sessions, you will participate in gait training with a physical therapist (PT). You will be asked to walk in 2-minute bouts and you will be provided with adequate rest breaks to help manage your fatigue levels. In addition to performing the gait training activities, you will be asked to perform thinking tasks at the same time. These pre-recorded questions or prompts will be provided to you through headphones and a portable music player. This is to help ensure that the PT is able to focus on giving you feedback about your walking ability and answers to the thinking tasks, and on your safety. At the end of each session, you will have walked for a total walking time of 20 minutes.

Dual-Task Gait

During the training sessions, you will participate in gait training with a physical therapist (PT). You will be asked to walk in 2-minute bouts and you will be provided with adequate rest breaks to help manage your fatigue levels. At the end of each session, you will have walked for a total walking time of 20 minutes.

Single-Task Gait

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability walk independently with or without an assistive device
  • Independent and community-dwelling
  • No history or presence of other clinically significant musculoskeletal, cardiovascular, respiratory, or neurologic disease.
  • Definite diagnosis of MS \[Expanded Disability Status Scale (EDSS) ≤6.5\]
  • Relapse free for the past 30 days and not currently receiving or will receive any rehabilitation services during the study.

You may not qualify if:

  • \- Participants experiencing a true relapse or exacerbation of their symptoms (\>24 hours duration in the absence infection or fever, or and ambient increase in body temperature) during the study will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Texas Woman's University Institute of Health Sciences - Houston Center

Houston, Texas, 77030, United States

RECRUITING

TIRR Memorial Hermann Adult and Pediatric Outpatient Rehabilitation at the Kirby Glen Center

Houston, Texas, 77030, United States

RECRUITING

MeSH Terms

Conditions

Multiple SclerosisGait Disorders, NeurologicCognitive Dysfunction

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Gregory Brusola, PT,DPT,MSCS

    Texas Woman's University & TIRR Memorial Hermann

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gregory A Brusola, PT,DPT,MSCS

CONTACT

Katy Mitchell, PT, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2018

First Posted

May 24, 2018

Study Start

May 31, 2018

Primary Completion

May 31, 2020

Study Completion

May 31, 2020

Last Updated

September 18, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations